'This can transform our communities': Four wāhine on a mission to harness hemp
Four wāhine are on a mission to uplift Māori communities, and they reckon hemp is the key.
Stay updated with breaking news from Rua Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Four wāhine are on a mission to uplift Māori communities, and they reckon hemp is the key.
Hikurangi Bioactives is freeing up capital to establish a kānuka industry. Rua Bioscience founder and major shareholder Hikurangi Bioactives has sold nearly half a million more shares in the NZX-listed cannabis company as it plots its next investment. Hikurangi Bioactives Limited Partnership (HBLP) originally owned 100% of Rua Bioscience Ltd and held 16.8% after the company listed on the NZX in a 50c IPO in October. HBLP was subject to full escrow until the company released its first set of half-year results to the NZ, which happened on February 26. At this point, it was able to sell up to...
Stock Takes: That sinking feeling - winners and losers from the NZX's latest listings 15 Apr, 2021 07:00 PM 7 minutes to read Harmoney chief executive David Stevens rings the bell at the company's listing on the NZX and ASX last year. Photo / Supplied Harmoney chief executive David Stevens rings the bell at the company's listing on the NZX and ASX last year. Photo / Supplied It's early days yet, but most of the sharemarket's latest debutants have not fared well since listing. In recent months eight new names have joined the NZX: Radius Healthcare, Auckland Real Estate, Harmoney, Ru...
Hikurangi Bioactives Limited Partnership sold nearly a million shares in the past month.
Cannabis company Medical Kiwi declined NZX listing 9 Apr, 2021 01:00 AM 6 minutes to read Medical Kiwi has been denied a listing on the NZX. Photo / 123RF Cannabis company Medical Kiwi - the subject of "ongoing inquiries" by the financial markets regulator - has been denied a listing on the NZX. NZ RegCo chief executive, Joost van Amelsfort, responsible for NZX regulation, confirmed the stock exchange has declined Medical Kiwi's application and determined the company is "not suitable for a direct listing at this time." A Financial Markets Authority (FMA) spokesman said its i...